Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension - The Lancet
Table 2 from Metabolic Acidosis of CKD: An Update. | Semantic Scholar
Metabolic acidosis and progression of chronic kidney disease: incidence, pathogenesis, and therapeutic options | Nefrología (English Edition)
Acid/Base Disorders: Metabolic Acidosis - Renal and Urology News
Metabolic acidosis in maintenance dialysis patients: Clinical considerations - Kidney International
Figure 1 from Treatment of acute non-anion gap metabolic acidosis | Semantic Scholar
Acid/Base Disorders: Metabolic Acidosis - Renal and Urology News
Practical approaches to the nutritional management of metabolic... | Download Scientific Diagram
Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial - The Lancet
Metabolic Acidosis and Subclinical Metabolic Acidosis in CKD | American Society of Nephrology
Metabolic Acidosis in CKD: Core Curriculum 2019 - American Journal of Kidney Diseases
AJKD on Twitter: "Non–Anion Gap Metabolic Acidosis: A Clinical Approach to Evaluation https://t.co/WKqlY0KCAX @dgsomucla… "